Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Fate Therapeutics
FATE
$270M
| $90.3M | 0.04% |
1,542,604
-179,207
| -10% | -$10.2M |
|
|
MGP
377
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $89.3M | 0.04% |
2,184,000
+164,402
| +8% | +$6.43M |
|
378
Lumen
LUMN
$6.38B
| $89.2M | 0.04% |
7,111,444
-2,039,701
| -22% | -$26M |
|
379
Factset
FDS
$10.1B
| $88.9M | 0.04% |
182,991
+88,645
| +94% | +$39.8M |
|
380
State Street
STT
$50.2B
| $88.9M | 0.04% |
955,931
+66,293
| +7% | +$6.25M |
|
381
Donaldson
DCI
$11.1B
| $88.7M | 0.04% |
1,496,725
-305,903
| -17% | -$18.1M |
|
382
Jones Lang LaSalle
JLL
$15.9B
| $87.9M | 0.04% |
326,116
+121,741
| +60% | +$31.4M |
|
383
GrafTech
EAF
$200M
| $87.7M | 0.04% |
741,509
-392,698
| -35% | -$45.5M |
|
384
Cardinal Health
CAH
$54.5B
| $87.2M | 0.04% |
1,692,895
-2,257,281
| -57% | -$111M |
|
385
Valvoline
VVV
$5.13B
| $87.1M | 0.04% |
2,335,922
-45,248
| -2% | -$1.58M |
|
386
Waste Management
WM
$96.1B
| $87.1M | 0.04% |
521,813
-53,280
| -9% | -$8.57M |
|
387
Skyworks Solutions
SWKS
$9.73B
| $86.9M | 0.04% |
560,067
+523,821
| +1,445% | +$83.8M |
|
|
MYOV
388
DELISTED
Myovant Sciences Ltd.
MYOV
| $86.1M | 0.04% |
5,527,464
-151,586
| -3% | -$2.89M |
|
389
Occidental Petroleum
OXY
$53.6B
| $85.7M | 0.04% |
2,954,946
+2,782,824
| +1,617% | +$87.3M |
|
390
Moody's
MCO
$83.9B
| $85.6M | 0.04% |
219,238
-21,712
| -9% | -$8.37M |
|
391
IPG Photonics
IPGP
$3.57B
| $85.3M | 0.04% |
495,842
+53,067
| +12% | +$8.77M |
|
392
Travelers Companies
TRV
$82.9B
| $85.3M | 0.04% |
545,374
-689,508
| -56% | -$108M |
|
393
Martin Marietta Materials
MLM
$35B
| $85.1M | 0.04% |
193,285
+65,497
| +51% | +$26.5M |
|
394
Alnylam Pharmaceuticals
ALNY
$38.5B
| $85M | 0.04% |
501,333
+479,756
| +2,223% | +$89.2M |
|
395
Alight
ALIT
$523M
| $83.8M | 0.03% |
387,405
+44,072
| +13% | +$9.57M |
|
396
Mondelez International
MDLZ
$80.2B
| $83.4M | 0.03% |
1,257,304
+151,810
| +14% | +$9.37M |
|
397
Dell
DELL
$253B
| $83.1M | 0.03% |
1,478,651
-830,165
| -36% | -$46.3M |
|
|
GWB
398
DELISTED
Great Western Bancorp, Inc.
GWB
| $82.9M | 0.03% |
2,440,718
+165,836
| +7% | +$5.66M |
|
399
Iron Mountain
IRM
$37.4B
| $82.6M | 0.03% |
1,578,972
+619,903
| +65% | +$29.3M |
|
|
CLVT.PRA
400
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $82.4M | 0.03% |
+910,077
| New | +$81.9M |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.